Immunocore (IMCR) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Immunocore

    NASDAQ: IMCR · Real-Time Price · USD
    36.64
    -0.56 (-1.51%)
    At close: Sep 08, 2025, 3:59 PM
    36.64
    0.00%
    After-hours: Sep 08, 2025, 04:10 PM EDT

    Immunocore Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -51.09M -43.37M -52.54M -133.13M
    Depreciation & Amortization
    		 4.2M 4.09M 6.13M 7.59M
    Stock-Based Compensation
    		 34.19M 32.47M 32.89M 48.89M
    Other Working Capital
    		 50.2M 21.03M 19.2M -11.66M
    Other Non-Cash Items
    		 -6.38M 3.97M -96.67K 317.79K
    Deferred Income Tax
    		 n/a n/a -2.92M -12.69M
    Change in Working Capital
    		 45.13M 5.78M -24.16M -16.81M
    Operating Cash Flow
    		 26.06M 2.94M -40.71M -105.82M
    Capital Expenditures
    		 -5.17M -5.42M -2.2M -1.01M
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 -350M n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 44K -1.17M 2.43M 513K
    Investing Cash Flow
    		 -355.13M -5.42M 233K -495K
    Debt Repayment
    		 352.5M n/a -1.65M n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -8.62M 34.35M 365.44K -10.63M
    Financial Cash Flow
    		 343.88M 34.35M 138.23M 276.25M
    Net Cash Flow
    		 13.11M 40.15M 114.31M 146.03M
    Free Cash Flow
    		 20.89M -2.48M -33.47M -130.76M

    Add to Watchlist